BRIEF-Ipsen says MHRA has approved a new indication for Decapeptyl
March 13, 2017 at 01:59 AM EDT
* Ipsen announces mhra1 approval of new indication for Decapeptyl® for the treatment of pre-menopausal women with early stage breast cancer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.